Are you up to date on the latest information on frontline induction, consolidation, and maintenance regimens for patients with newly diagnosed myeloma?
New approaches promise to transform care in multiple myeloma again. Read my thoughts on the most promising novel agents in clinical trial!
Gain practical insights for your care of patients with relapsed/refractory myeloma
Suzanne Lentzsch, MD, PhD, talks about her experiences with COVID-19 as she cares for patients with myeloma.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.